Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 9, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

December 31, 2027

Conditions
Mitral RegurgitationMitral Valve DiseaseMitral Valve InsufficiencyMitral Valve ProlapseHeart Valve Diseases
Interventions
DEVICE

NeoChord Artificial Chordae Delivery System, Model DS1000

The intended use of the device is for the placement of artificial chordae when the natural chordae tendinae have become elongated or ruptured due to degenerative valve disease.

Trial Locations (5)

Unknown

RECRUITING

University of Bonn, Bonn

RECRUITING

CVC Frankfurt, Frankfurt

RECRUITING

University of Mainz, Mainz

RECRUITING

Hippokration Hospital, Athens

RECRUITING

Triemli Hospital, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

NeoChord

INDUSTRY

NCT04190602 - Multicenter Post-Market Observational Registry of the NeoChord Artificial Chordae Delivery System | Biotech Hunter | Biotech Hunter